Ethical issues in adolescent HIV research in resource-limited countries

Journal of Acquired Immune Deficiency Syndromes

Volumn 65, Issue SUPPL.1, 2014, Pages

  Bekker, Linda Gail ^a   Slack, Catherine ^b   Lee, Sonia ^c   Shah, Seema ^d   Kapogiannis, Bill ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Adolescents; Ethics; Informed consent

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL RESEARCH; DEVELOPING COUNTRY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PEDIATRICS; PRIORITY JOURNAL; RESEARCH ETHICS; RESEARCH SUBJECT; SCIENTIST; VULNERABLE POPULATION; YOUNG ADULT; ADOLESCENT HEALTH; HEALTH CARE PLANNING; HIGH RISK POPULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; INFORMED CONSENT; LAW; MANDATORY REPORTING; MEDICAL AUDIT; MEDICAL RESEARCH; PARENTAL CONSENT; PRIVACY; RISK ASSESSMENT;

EID: 84890936129     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000036     Document Type: Article

References (40)

1. UNAIDS. Fact Sheet-2012. Available at: http://www.unaids. org/en/media/unaids/contentassets/documents/factsheet/2012/20120417-FS- adolescentsyoungpeoplehiv-en.pdf. Accessed August 1, 2013.
2. World Health Organization and Joint United Nations Programme on HIV/AIDS. Global HIV/AIDS response: epidemic update and health sector progress towards Universal Access. Available at: http://www. unaids.org/en/media/unaids/ contentassets/documents/unaidspublication/ 2011/20111130-ua-report-en.pdf. Accessed August 1, 2013.
3. New approaches to HIV prevention: accelerating research and ensuring future access. Global HIV Prevention Working Group. Available at: http://www.globalhivprevention.org/pdfs/New%20Prevention% 20Approaches.pdf. Accessed August 1, 2006.
4. Kuritzkes D. Ethical conducts of research in resource-limited settings. J Infect Dis. 2004;189: 764-765. (Pubitemid 38328175)
5. Nelson RM, Lewis LL, Struble K, et al. Ethical and regulatory considerations for the inclusion of adolescents in HIV biomedical prevention research. J Acquir Immune Defic Syndr. 2010;54:S18-S24.
6. Ott MA, Alexander AB, Lally M, et al. Preventive misconception and adolescents' knowledge about HIV vaccine trials.J Med Ethics. 2013; [Epub ahead of print; January 25, 2013; doi: 10.1136/medethics-2012-100821].
7. Tanner AE, Philbin MM, Duval A, et al. "Youth friendly" clinics: considerations for linking and engaging HIV-infected adolescents into care. AIDS Care. 2013; [Epub ahead of print; June 20, 2013].
8. Philbin MM, Tanner AE, Duval A, et al. Linking HIV-positive adolescents to care in 15 different clinics across the United States: creating solutions to address structural barriers for linkage to care. AIDS Care. 2013; [Epub ahead of print; June 18, 2013].
9. Whiteley L, Brown L, Swenson R, et al. Mental health care among HIVinfected youth in medical care: disparities and equalities. J Intl Assoc Physicians AIDS Care. 2013; [Epub ahead of print; May 21, 2013].
10. Lee S, Kapogiannis B, Flynn P, et al. Comprehension of a simplified assent form in a vaccine trial for adolescents. J Med Ethics. 2013;39: 410-412.
11. Hosek S, Siberry G, Bell M, et al. The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. J Acquir Immune Defic Syndr. 2013;62:447.
12. Pace JE, Siberry GK, Hazra R, et al. HIV pre-exposure prophylaxis in adolescents at risk: is an ounce of prevention worth a pound of cure? Clin Infect Dis. 2013;56: 1149-1155.
13. Kapogiannis BG, Mattison DR. Adolescents in clinical trials. Clin Pharmacol Ther. 2008;84: 655-659.
14. Kapogiannis BG, Lee SS. Rolling up our sleeves now to reap the benefits later: preparing the community for an adolescent HIV vaccine. Curr Opin HIV AIDS. 2007;2: 375-384. (Pubitemid 47254732)
15. Abdool Karim Q, Kharsany AB, Frohlich JA, et al. HIV incidence in young girls in KwaZulu-Natal, South Africa-public health imperative for their inclusion in HIV biomedical intervention trials. AIDS Behav. 2012; 16: 1870-1876.
16. The Adolescent and Young Adult oncology Progress Review Group. Closing the Gap: A Strategic Plan: addressing the recommendations of the adolescent and young adult oncology progress review Group. Available at: http://www.livestrong. org/pdfs/LAF-YAA-Report-pdf. Accessed November 19, 2013.
17. Emanuel EJ, Wendler D, Killen J, et al. What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis. 2004:189: 930-937. (Pubitemid 38328195)
18. UNAIDS/AVAC (2011). Good participatory practice: guidelines for biomedical HIV prevention trials. Geneva: UNAIDS. Available at: http:// www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/ 2011/JC1853-GPP-Guidelines-2011-en.pdf. Accessed August 1, 2013.
19. Ellen JM, Wallace M, Sawe FK, et al. Community engagement and investment in biomedical HIV prevention research for youth: rationale, challenges, and approaches. J Acquir Immune Defic Syndr. 2010;54:S7-S11.
20. Strode AE, Slack CM, Wassenaar DR, et al. One step forward, two steps back - requiring ministerial approval for all "non-therapeutic" health research involving minors. S Afr Med J. 2007;97: 200-202. (Pubitemid 46455886)
21. Evans Chan T. The search for minimal risk in international paediatric clinical trials, 5 Santa Clara J Int'l L. 2006. Available at: http:// digitalcommons.law.scu.edu/scujil/vol5/iss1/2. Accessed August 1, 2013.
22. Snyder J, Miller CL, Gray G. Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: expanding the debate. Am J Bioeth. 2011;11: 5-13.
23. Shah S. Commentary: the dangers of using a relative standard for minimal risk. Am J Bioeth. 2011;11: 22-23.
24. Bekker LG, Jaspan H, McIntyre J, et al. Adolescents and HIV vaccine trials: what are the clinical trial site issues? J Int Assoc Physicians AIDS Care (Chic). 2005;4: 93-97.
25. Slack C, Strode A, Fleischer T, et al. Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa. BMC Med Ethics. 2007;8:5.
26. Shah S, Whittle A, Wilfond B, et al. How do institutional review boards apply the federal risk and benefit standards for pediatric research? JAMA. 2004;291: 476-482. (Pubitemid 38129752)
27. Essack Z, Slack C, Strode A. Towards a roadmap: summary of identified ethical-legal complexities in adolescent HIV vaccine & microbicide research. Global Campaign for Microbicides, 2008. Available at: http://www.global- campaign.org/clientfiles/Essack-Slack-Strode(2008) Towards-a-Roadmap.pdf. Accessed January 2013.
28. Iltis AS. Parents, adolescents, and consent for research participation. J Med Philos. 2013;38: 332-346.
29. Flory J, Emanuel E. Interventions to improve research participants understanding in informed consent for research: a systematic review. JAMA. 2004;292: 1593-1601. (Pubitemid 39314966)
30. Lindegger G, Milford C, Slack C, et al. Beyond the checklist: assessing understanding for HIV vaccine trial participation in South Africa. J Acquir Immune Defic Syndr. 2006;43: 560-566. (Pubitemid 44885623)
31. Wendler D, Rackoff JE, Emanuel EJ, et al. The ethics of paying for children's participation in research. J Pediatr. 2002;141: 166-171.
32. Largent E, Grady C, Miller FG, et al. Misconceptions about coercion and undue influence: reflections on the views of IRB members. Bioethics. 2013;27: 500-507.
33. Participants in the 2006 Georgetown UniversityWorkshop on the Ancillary- Care Obligations of Medical Researchers Working in Developing Countries. The ancillary-care obligations of medical researchers working in developing countries. PLoS Med. 2008;5:e90.
34. MacDonell K, Naar-King S, Huszti H, et al. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav. 2013;17: 86-93.
35. Marrazzo J, Ramjee G, Nair G, et al. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003). Paper presented at: Conference on Retroviruses and Opportunistic Infections; 2013; Atlanta, GA.
36. Mastroianni AC, Faden R, Federman D, eds. Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies. Washington, DC: National Academy Press; 1994. Available at: http://www. nap.edu/openbook.php? isbn=030904992X. Accessed August 1, 2013.
37. Macklin R. Reversing the presumption: the IOM report on women in health research. J Am Med Womens Assoc. 1994;49:113-116, 121.
38. Lyerly AD, Little MO, Faden RR. Reframing the framework: toward fair inclusion of pregnant women as participants in research. Am J Bioeth. 2011;11: 50-52.
39. Hosek SG, Zimet GD. Behavioral considerations for engaging youth in HIV clinical research. J Acquir Immune Defic Syndr. 2010;54: S25-S30.
40. Rudy BJ, Kapogiannis BG, Lally MA, et al. Youth-specific considerations in the development of pre-exposure prophylaxis, microbicide, and vaccine research trials. J Acquir Immune Defic Syndr. 2010;54:S31-S42.